Source comparison
MK-677 Not Working: Comparison of Common Failure Points
Insufficient Dose Ghrelin receptor occupancy below threshold for sustained GH pulse amplification No measurable appetite increase, no water retention in first week Escalate from 10mg to 20–25mg daily over 7–10 days 10mg works for some, but 20–25mg is the resea
This comparison does not assign a generated winner or score.
- Insufficient Dose
- Ghrelin receptor occupancy below threshold for sustained GH pulse amplification
- No measurable appetite increase, no water retention in first week
- Escalate from 10mg to 20–25mg daily over 7–10 days
- 10mg works for some, but 20–25mg is the research-validated range for consistent IGF-1 elevation
- Poor Timing (with meals)
- Insulin spike suppresses GH release via somatostatin activation
- Subjective energy boost but no body composition change after 4–6 weeks
- Dose on empty stomach, minimum 3 hours post-meal, ideally before bed
- Timing isn't optional. It's the difference between 40% GH response and 90% GH response
- Receptor Desensitization
- Continuous high-dose agonism downregulates GHS-R1a density over 8–12 weeks
- Initial appetite/sleep improvement fades after week 6–8 despite continued dosing
- Cycle 8 weeks on, 4 weeks off to allow receptor upregulation
- Chronic daily use without breaks is the fastest path to diminishing returns
- Product Degradation
- Heat exposure denatures peptide structure, rendering it biologically inactive
- Liquid formulation color shift (clear → amber), no appetite increase within 48 hours
- Store lyophilized powder at −20°C; discard liquid formulations older than 30 days
- If the compound has been stored improperly, you're injecting inactive protein fragments. Not ibutamoren
- Metabolic Antagonism
- Chronic cortisol elevation or severe caloric deficit suppresses hepatic IGF-1 synthesis
- Low energy, poor recovery, plateau despite compliance with dosing protocol
- Address sleep debt (7+ hours nightly), cycle caloric deficit with maintenance phases
- MK-677 amplifies existing GH signaling. It can't override a broken metabolic baseline